Angela Cacace, Ph.D.

Angela Cacace, Ph.D.

Chief Scientific OfficeratArvinas· In proxies 2024–2025

Pay in FY2025+11% from the year before · Arvinas stock -38.1% the same year

Angela Cacace, Ph.D. was paid $3.3M in FY2025 (Dec), up 11%. Arvinas stock fell 38.1% that year.

Pay$100 in the stock at the end of FY23 → $29
Pay is from the Summary Compensation Table of each Arvinas proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. ArvinasPublic company · 2 yr
    • Chief Scientific Officer2024 – Present · 2 yrStock in role -82%

Roles come from the proxy statements of each company.

Activity

Two people shown as one, or a wrong number?